Philip Kell

425 total citations
16 papers, 290 citations indexed

About

Philip Kell is a scholar working on Psychiatry and Mental health, Endocrinology, Diabetes and Metabolism and Clinical Psychology. According to data from OpenAlex, Philip Kell has authored 16 papers receiving a total of 290 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Psychiatry and Mental health, 6 papers in Endocrinology, Diabetes and Metabolism and 4 papers in Clinical Psychology. Recurrent topics in Philip Kell's work include Sexual function and dysfunction studies (9 papers), Hormonal and reproductive studies (6 papers) and Sexuality, Behavior, and Technology (4 papers). Philip Kell is often cited by papers focused on Sexual function and dysfunction studies (9 papers), Hormonal and reproductive studies (6 papers) and Sexuality, Behavior, and Technology (4 papers). Philip Kell collaborates with scholars based in United Kingdom, United States and Finland. Philip Kell's co-authors include David Ralph, Ian Eardley, Francesco Montorsi, Margaret R. Warner, Anthony Beardsworth, Vincenzo Mirone, Yanli Zhao, Gillian Mezey, Adrian Coxell and Glen Jeffery and has published in prestigious journals such as British Journal of Urology, Journal of Vision and Maturitas.

In The Last Decade

Philip Kell

15 papers receiving 279 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Philip Kell United Kingdom	9	171	118	99	53	31	16	290
Ahmad Fakhri Iran	9	165 1.0×	59 0.5×	46 0.5×	26 0.5×	36 1.2×	31	352
Irene Scavello Italy	12	270 1.6×	187 1.6×	70 0.7×	26 0.5×	28 0.9×	21	413
Stéphanie C. Boyer Canada	11	217 1.3×	47 0.4×	94 0.9×	22 0.4×	17 0.5×	14	346
Loukas Athanasiadis Greece	11	172 1.0×	91 0.8×	115 1.2×	46 0.9×	20 0.6×	26	359
Sydney Thomson Canada	5	174 1.0×	59 0.5×	92 0.9×	43 0.8×	6 0.2×	5	273
A. J. Riley United Kingdom	9	252 1.5×	141 1.2×	113 1.1×	72 1.4×	27 0.9×	18	350
Mark Hirsch United States	4	308 1.8×	280 2.4×	102 1.0×	56 1.1×	65 2.1×	6	456
Laurie J. Legocki United States	8	281 1.6×	76 0.6×	72 0.7×	29 0.5×	3 0.1×	13	417
Silvia Cerpolini Italy	8	51 0.3×	182 1.5×	94 0.9×	31 0.6×	90 2.9×	10	464
Kathryn May United Kingdom	7	583 3.4×	102 0.9×	364 3.7×	125 2.4×	34 1.1×	10	643

Countries citing papers authored by Philip Kell

Since Specialization

Citations

This map shows the geographic impact of Philip Kell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip Kell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip Kell more than expected).

Fields of papers citing papers by Philip Kell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip Kell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip Kell. The network helps show where Philip Kell may publish in the future.

Co-authorship network of co-authors of Philip Kell

This figure shows the co-authorship network connecting the top 25 collaborators of Philip Kell. A scholar is included among the top collaborators of Philip Kell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip Kell. Philip Kell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Mitchell, Laura E., et al.. (2015). P112 How integrated are we? a bashh bccg survey of gum and sexual health clinics in the UK. Sexually Transmitted Infections. 91(Suppl 1). A53.1–A53. 1 indexed citations

Kell, Philip, et al.. (2013). Holding up the mirror: how to use quality assurance, peer review to improve sexual health. Sexually Transmitted Infections. 89(8). 616–619.

Wylie, Kevan, Margaret Rees, Geoff Hackett, et al.. (2010). Androgens, health and sexuality in women and men. Maturitas. 67(3). 275–289. 44 indexed citations

Wylie, Kevan, Margaret Rees, Geoff Hackett, et al.. (2010). Androgens, health and sexuality in women and men. Human Fertility. 13(4). 277–297. 13 indexed citations

Kell, Philip. (2009). Patient preference and satisfaction in erectile dysfunction therapy: a comparison of the three phosphodiesterase-5 inhibitors sildenafil, vardenafil and tadalafil. Patient Preference and Adherence. 3. 99–99. 28 indexed citations

Kell, Philip, et al.. (2007). Factors that predict changing the type of phosphodiesterase type 5 inhibitor medication among men in the UK. British Journal of Urology. 99(4). 860–863. 14 indexed citations

Stockman, Andrew, Lindsay T. Sharpe, Adnan Tufail, et al.. (2007). The effect of sildenafil citrate (Viagra®) on visual sensitivity. Journal of Vision. 7(8). 4–4. 36 indexed citations

Ralph, David, Ian Eardley, Philip Kell, et al.. (2007). Improvement in erectile function on vardenafil treatment correlates with treatment satisfaction in both patients and their partners. British Journal of Urology. 100(1). 130–136. 23 indexed citations

Eardley, Ian, Vincenzo Mirone, Francesco Montorsi, et al.. (2005). An open‐label, multicentre, randomized, crossover study comparing sildenafil citrate and tadalafil for treating erectile dysfunction in men naïve to phosphodiesterase 5 inhibitor therapy. British Journal of Urology. 96(9). 1323–1332. 70 indexed citations

10.

Wright, Simon, et al.. (2004). How do clients access their HIV test results from genitourinary medicine services in the UK? A time for change!. International Journal of STD & AIDS. 15(9). 584–586. 5 indexed citations

11.

Kell, Philip. (2002). Cardiovascular safety of sildenafil. International Journal of STD & AIDS. 13(7). 439–443. 1 indexed citations

12.

Kell, Philip, John Dean, & David Ralph. (2002). Apomorphine SL in the treatment of erectile dysfunction. The British Journal of Diabetes. 2(4). 296–300. 1 indexed citations

13.

Nandwani, Rak, et al.. (2002). Medical management of sexual difficulties in HIV-positive individuals. International Journal of STD & AIDS. 13(9). 587–592. 15 indexed citations

14.

Kell, Philip. (2001). The provision of sexual dysfunction services by genitourinary medicine physicians in the UK, 1999. International Journal of STD & AIDS. 12(6). 395–397. 5 indexed citations

15.

Coxell, Adrian, et al.. (2000). Sexual molestation of men: interviews with 224 men attending a genitourinary medicine service. International Journal of STD & AIDS. 11(9). 574–578. 29 indexed citations

16.

McCormack, William M., David H. Martin, Edward W. Hook, et al.. (1999). Double-Blind Comparison of Trovafloxacin and Doxycycline in the Treatment of Uncomplicated Chlamydial Urethritis and Cervicitis. Sexually Transmitted Diseases. 26(9). 531–536. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact